ACTU · Actuate Therapeutics, Inc. · Exempt Offerings
$0.30
+0.01 (+1.75%)
At close · Nov 11
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$7.26M
Shares
24.01M
Volume · Nov 11
94.93K
Avg daily vol (3M)
422.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-07-07 | New | Pharmaceuticals | $9,330,958 | $4,665,479 | 06b |
| 2025-04-10 | New | Pharmaceuticals | $50,000,000 | $0 | 06b |
| 2024-03-06 | New | Pharmaceuticals | $5,000,000 | $3,000,000 | 06b |
| 2022-12-15 | Amendment | Pharmaceuticals | $50,000,000 | $19,336,491 | 06b |
| 2022-10-19 | New | Pharmaceuticals | $50,000,000 | $11,170,000 | 06b |
| 2020-12-10 | New | Pharmaceuticals | $50,000,000 | $14,482,301 | 06b |
Showing 1–6 of 6 filings
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
18 filings
18 filers
Visit website
Investor relations